A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19.
The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority (HSA) in response to CNA's queries on Tuesday (Apr 19).
Singapore's Health Sciences Authority (HSA) has recently given the approval to conduct a clinical trial on the use of Lianhua Qingwen capsules among Covid-19 patients in Singapore.
SINGAPORE - A clinical trial is currently under way here to see if traditional Chinese medicine (TCM) Lianhua Qingwen Jiao Nang capsules can help in the treatment of some Covid-19 patients.
HQ Office & TOA PAYOH Branch:
640 Lorong 4 Toa PayohSingapore 319522 Tel: 62513304
BLK 215 Yishun Street 21, #01-301 Singapore 760215 Tel: 6756 7830
BLK 679 Woodlands Avenue 6 #01-710 Singapore 730679 Tel: 6366 3246
JOO CHIAT Branch:
291 Joo Chiat Road, JK Centre #02-01 Singapore 427543 Tel: 6444 8727
BUKIT PANJANG Branch:
BLK123 Pending Road, #01-42 Singapore 670123 Tel: 6766 7576
医席管理 / e-HR 系统